Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment
Therefore, while GLP-1RAs may represent a promising therapeutic option for managing psoriasis, further high-quality studies are needed to distinguish whether the therapeutic effects of GLP-1RAs originate from the direct regulation of immune cells or improvements in comorbidities such as obesity or diabetes
Clinical Background BPC-157 was introduced in 1993 and initially studied as a potential treatment for inflammatory bowel disease due to its anti-ulcer effects
doi: 10.1016/j.yexcr.2020.112061 91 ChangCCHungCMYangYRLeeMJHsuYC
Patients should expect continued follow-up, medication monitoring, and conversations about nutrition, activity, side effects, and progress
For most people on GLP-1 medications, a target of 1.6 to 2.2 grams of protein per kilogram of body weight daily is appropriate